Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape The rheumatoid arthritis ...
Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells ...
TNX-1700 (TFF2-albumin fusion protein) reversed aging-associated gastric inflammation and significantly attenuated tumor progression in aged ...
2don MSN
Key molecular dynamic could boost cancer treatments while limiting stem cell transplant rejection
A key molecular dynamic could be the key to fighting tumors while allowing patients to still receive life-saving cell ...
Non-Hodgkin lymphoma (NHL) is a group of hematologic malignancies that originate from lymphocytes known as B or T cells. This ...
Phase 2 studies ongoing to advance global development of vebreltinib, a highly potent, de-risked and differentiated c-MET Inhibitor with ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Researchers at the Josep Carreras Leukaemia Research Institute (IJC) discover that a single molecular switch, HDAC7, controls ...
Percheron Therapeutics Ltd (ASX:PER, OTC:PERCF) has presented new phase I clinical data for its cancer therapy candidate HMBD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results